Recently, the FDA announced the removal of certain compounded GLP1 ingredients from its drug shortage list. These ingredients are found in: The drug products were in shortage since 2020. The FDA had ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.

Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Ready to transform your body? It's possible with this program's personalized care, telehealth consultations, and semaglutide ...

Doctors are learning more about the wider effects of the injections, from lowering blood pressure to helping people quit ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...